Progression rate of newly diagnosed impaired fasting glycemia to type 2 diabetes mellitus: A study using the National Healthcare Group Diabetes Registry in Singapore

被引:8
作者
Ang, Yee Gary [1 ]
Wu, Christine Xia [1 ]
Toh, Matthias Paul Han Sim [1 ]
Chia, Kee Seng [2 ]
Heng, Bee Hoon [1 ]
机构
[1] Natl Healthcare Grp, Singapore 149547, Singapore
[2] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore
关键词
diabetes mellitus; impaired fasting glycemia; Singapore; LIFE-STYLE INTERVENTION; FOLLOW-UP; GLUCOSE-TOLERANCE; RISK; POPULATION; REDUCTION;
D O I
10.1111/j.1753-0407.2011.00169.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The aims of the present study were to estimate the rate of progression from newly diagnosed impaired fasting glycemia (IFG) to type 2 diabetes mellitus (T2DM) in Singapore and to identify factors associated with the progression to T2DM in individuals with newly diagnosed IFG. Methods: The present study was a retrospective cohort study of newly diagnosed IFG from the National Healthcare Group Diabetes Registry between 1 January 2006 and 31 December 2007 to estimated the rate of progression to T2DM. Univariate survival analysis, followed by multivariate survival analysis, was performed and interactions were tested in the final model. Results: Over a mean follow-up period of 1.65 +/- 0.13 years, 85 of 490 participants with newly diagnosed IFG developed T2DM, giving an annual progression rate of 6.8%. The factors associated with the development of T2DM were higher fasting plasma glucose level in the year of IFG diagnosis (hazard ratio [HR] = 14.6; 95% confidence interval [CI] 5.66-37.5), Chinese race (HR = 2.70; 95% CI 1.44-5.06), and body mass index (HR = 1.11; 95% CI, 1.06-1.15). Conclusions: The progression rate to T2DM is high in subjects with newly diagnosed IFG. Intensive lifestyle modification can be incorporated into their current yearly follow-up to prevent progression to T2DM, which is a growing problem in Singapore.
引用
收藏
页码:159 / 163
页数:5
相关论文
共 17 条
[1]  
[Anonymous], NAT HLTH SURV 2004
[2]  
[Anonymous], CLIN GUID PRIM CAR
[3]   Impaired fasting glucose and risk of diabetes in Taiwan: follow-up over 3 years [J].
Chen, KT ;
Chen, CJ ;
Gregg, EW ;
Imperatore, G ;
Narayan, KMV .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 60 (03) :177-182
[4]   Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population - The Hoorn study [J].
de Vegt, F ;
Dekker, JM ;
Jager, A ;
Hienkens, E ;
Kostense, PJ ;
Stehouwer, CDA ;
Nijpels, G ;
Bouter, LM ;
Heine, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (16) :2109-2113
[5]   Effects of changing diagnostic criteria on the risk of developing diabetes [J].
Dinneen, SF ;
Maldonado, D ;
Leibson, CL ;
Klee, GG ;
Li, HZ ;
Melton, LJ ;
Rizza, RA .
DIABETES CARE, 1998, 21 (09) :1408-1413
[6]   Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies [J].
Gerstein, Hertzel C. ;
Santaguida, Pasqualina ;
Raina, Parminder ;
Morrison, Katherine M. ;
Balion, Cynthia ;
Hunt, Dereck ;
Yazdi, Hossein ;
Booker, Lynda .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 78 (03) :305-312
[7]  
Heng BH, 2010, ANN ACAD MED SINGAP, V39, P348
[8]   Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose - Results from the LIPID trial [J].
Keech, A ;
Colquhoun, D ;
Best, J ;
Kirby, A ;
Simes, RJ ;
Hunt, D ;
Hague, W ;
Beller, E ;
Arulchelvam, M ;
Baker, J ;
Tonkin, A .
DIABETES CARE, 2003, 26 (10) :2713-2721
[9]  
Knowler William C, 2002, N Engl J Med, V346, P393, DOI 10.1056/NEJMoa012512
[10]   Change of glycaemic status in Chinese subjects with impaired fasting glycaemia [J].
Ko, GTC ;
Chan, JCN ;
Cockram, CS .
DIABETIC MEDICINE, 2001, 18 (09) :745-748